TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote July 2, 1999
TCL Archive OMB Caused The Problem But Did Not Order Transfer Of $20 Million From Centers Program to Grants Poll April 29, 1983
TCL Archive In Brief: Three Comprehensive Centers Have Problems But Aren’t On “Probation”; Amos On Budget June 9, 1978
